Home Stock

Stock Research: Raia Drogasil

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Raia Drogasil

SAO:RADL3 BRRADLACNOR0
45
  • Value
    22
  • Growth
    87
  • Safety
    Safety
    20
  • Combined
    32
  • Sentiment
    75
  • 360° View
    360° View
    45
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Raia Drogasil S/A is a Brazilian company focused on the retail sale of pharmaceutical and cosmetic products. It operates in the retail pharmacy industry, selling branded and generic medications, OTC medications, and personal hygiene products. The company primarily operates in Brazil, across all federal units. In the last fiscal year, the company had a market cap of $4,152 million, profits of $1,871 million, and revenue of $6,292 million, with 64758 employees.

more

ANALYSIS: With an Obermatt 360° View of 45 (better than 45% compared with alternatives), overall professional sentiment and financial characteristics for the stock Raia Drogasil are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Raia Drogasil. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 87% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 75, which means that professional investors are more optimistic about the stock than for 75% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 22, which means that the share price of Raia Drogasil is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 78% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 20, which means that the company has a financing structure that is riskier than those of 80% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Strongest Rank Price vs. Book (P/B)
Weakest Rank Growth
Country Brazil
Industry Drug Retail
Size X-Large
Website rdsaude.com.br
Index
BOVESPA
Renewables Users
Raia Drogasil stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
22 19 7 11
Growth
87 55 97 83
Safety
Safety
20 57 50 48
Sentiment
75 46 77 85
360° View
360° View
45 37 60 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
49 44 45 26
Opinions Change
50 35 50 64
Pro Holdings
n/a 55 73 93
Market Pulse
56 67 84 68
Sentiment
75 46 77 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
22 19 7 11
Growth
87 55 97 83
Safety Safety
20 57 50 48
Combined
32 32 50 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
44 49 25 36
Price vs. Earnings (P/E)
19 29 15 32
Price vs. Book (P/B)
15 22 11 20
Dividend Yield
57 22 15 15
Value
22 19 7 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
76 92 90 75
Profit Growth
82 30 71 78
Capital Growth
37 82 65 69
Stock Returns
77 23 81 19
Growth
87 55 97 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
25 38 40 38
Refinancing
50 62 57 53
Liquidity
32 44 43 60
Safety Safety
20 57 50 48

Similar Stocks

Discover high‑ranked alternatives to Raia Drogasil and broaden your portfolio horizons.

Telefonica Brasil

SAO:VIVT3
Country: Brazil
Industry: Integrated Telecommunication
Size: X-Large
Full Stock Analysis

Cogna Educacao

SAO:COGN3
Country: Brazil
Industry: Education Services
Size: Medium
Full Stock Analysis

Vivara Participações

SAO:VIVA3
Country: Brazil
Industry: Apparel, Accessories, Luxury
Size: Medium
Full Stock Analysis

Puregold Price Club

PHS:PGOLD
Country: Philippines
Industry: Hypermarkets, Super Centers
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews